The disclosure provides a class of pH-sensitive, helix/random conformation switchable antimicrobial polypeptide (HRS-AMP) compositions as a single agent to selectively kill bacteria (e.g., H. pylori) under acidic condition in the stomach with diminished bacterial resistance compared to currently used antibiotics. Methods of treating bacterial infections in the stomach are also provided.
Original languageEnglish (US)
U.S. patent number11225507
Filing date1/25/18
StatePublished - Jan 18 2022


Dive into the research topics of 'Conformation switchable antimicrobial peptides and methods of using the same'. Together they form a unique fingerprint.

Cite this